Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil once daily or on demand versus sildenafil on demand for treatment discontinuation in PDE5 inhibitor-naive erectile dysfunction
2009-011318-22Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tadalafil and sildenafil in erectile dysfunction (ED) (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: Time to discontinuation of randomized treatment. Started Feb 2010; status: completed.
02
Drugs
tadalafilsildenafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2009-011318-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011318-22.